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Aortobronchial fistula (ABF) is a rare, potentially fatal condition that results from an abnormal
communication between the aorta and the adjacent bronchial system.1 The etiology of
development of ABF is not fully understood, and can be either aortic or pulmonary. Most
reported ABF are aortic in nature secondary to previous aortic surgery, graft placement,
anastomotic line pseudoaneurysms, or aortic aneurysms.1-3 ABF can also be secondary to
pulmonary pathologies including pulmonary tuberculosis, aspergillus infection, and lung
transplantation.4-7 The most common presenting symptom in patients with ABF is hemoptysis,
which can be intermittent or acute and massive. Other symptoms include chest pain, cough,
and dyspnea.1-8
Case Report
[4]A 73-year-old male presented with a 10-day history of recurrent hemoptysis. The
patient described having expectorated around 2 tablespoons of gross blood with
each episode along with blood tinged coughing. Patient was otherwise
asymptomatic with no chest pain, shortness of breath, or chronic cough. His
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medication history consisted mainly of furosemide, antihypertensives, vitamins,
and aspirin. The patient had a past medical history of coronary artery bypass graft for coronary
artery disease and endovascular abdominal aortic aneurysm repair. Patient is a former smoker
who quit 8 years ago with a 40-pack/year history. Upon evaluation, the patient was
hemodynamically stable with unremarkable physical examination.
[5]Laboratory studies performed were unremarkable except for hyponatremia with a
sodium level of 127 mEq/L. Hemoglobin level was 13 g/dL. Spiral CT angiogram
with 3D reconstruction (Figures 1, 2, and 3) revealed saccular descending
thoracic aortic aneurysm approximately 4.9 cm in diameter with evidence of
contained rupture.
[6]The patient was brought to the operating room. We performed aortic arch and
descending aorta angiography and saw the origin of great vessels, innominate,
and left subclavian artery. We also noted the origin of the saccular aneurysm was
in close proximity to left subclavian artery takeoff (Figure 4). Intravascular
ultrasound was used and the aneurysm was found to be approximately 2.5 cm
distal to the takeoff of the left subclavian artery consistent with the CT angiogram. We inserted a
30 mm x 30 mm x 115 mm Talent thoracic endograft (Medtronic) through the right groin and
deployed barely adjacent to the distal edge of the left subclavian artery. [7]The
graft was ballooned. Intravascular ultrasound confirmed graft position and
deployment, which we found adequate. Completion angiogram revealed
successful exclusion of the aneurysm (Figure 5). A spinal catheter was inserted
intraoperatively to decrease risk of spinal cord ischemia. Also note that
prophylactic preoperative antibiotics were given with cefazolin and discontinued postoperatively.
[8]The patient was clinically and hemodynamically stable at postoperative
follow-up. He was kept overnight for observation. The spinal catheter was pulled
out on postoperative day 1 and he was discharged home, less than 24 H from
admission time.
The patient presented postoperatively with another episode of hemoptysis on postoperative day
12. He was otherwise asymptomatic and hemodynamically stable with unremarkable physical
examination. Bronchoscopy revealed necrotic residues with no active [9]bleed. CT
angiography revealed adequate graft position with aneurysm exclusion.
Hemoptysis resolved and patient continued to do well upon 4 months follow-up.
Since there are no guidelines upon follow-up, patient was seen 1 month and 4
months postoperatively, and will be seen at 6-month intervals thereafter for a
repeat CT scan and a physical exam.
Discussion
ABF is a rare condition commonly presenting with nonspecific symptoms such as hemoptysis,
chest pain, and dyspnea.1-8 Given the nonspecific nature of symptoms and the low index of
suspicion, the condition can be become rapidly fatal secondary to massive hemoptysis.9 When
left untreated, the condition carries a 100% mortality rate.10,11
Another setback with the diagnosis of ABF is the lack of noninvasive modalities that can
effectively make the diagnosis. CT angiography rarely demonstrates the ABF but can reveal
findings consistent with the diagnosis such as parenchymal hemorrhage with adjacent aortic
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aneurysmal dilatation.12,13
In our case the information provided from the CT angiography put in the clinical context of
hemoptysis hinted at the diagnosis of ABF. Aortography does not demonstrate the fistula tract
either.13 On the other hand, bronchoscopy can hint at the site of the fistula but should be
conducted very carefully as clot dislodgement of the fistula tract can potentially result in
massive hemorrhage.13
It should also be noted that recurrent hemoptysis after TEVAR for ABF as was the case with our
patient is not uncommon with 12% incidence. It frequently warrants diagnostic modalities to
evaluate adequacy of aneurysm exclusion, but often it is attributable to residual hematoma
being expectorated, as with our patient.11
Traditionally, management of ABF involves open surgical repair with mortality rate ranging from
15% to 41%.8,10 With endovascular stent graft repairs becoming a more established entity of
arterial aneurysmal repairs, thoracic endovascular aortic repair (TEVAR) for ABF offers a
minimally invasive approach with less morbidity and mortality than traditional open repair.8 In
our case the patient was admitted overnight and discharged home less than 24 H after the
endovascular repair. The short-term efficacy of TEVAR for ABF is mostly derived from small case
series and individual case reports as the paucity of the event makes it extremely difficult to
conduct large-scale studies.11
A concern with endovascular management for ABF has been graft infection given the potential
exposure of the graft to bronchial secretions. However, the data available reveals minimal risk of
infection following TEVAR for ABF, which is poorly understood and might be due to minimizing
the trauma to contaminated tissue planes as compared to open repair.7
In his series of 11 patients followed up at a mean of 8.8 months, Bailey et al8 reports a technical
success rate of 91% (10 patients) with only one reported endoleak requiring further intervention.
It is important to mention that 6 of the 11 patients in the reported series had previous thoracic
aortic surgery. Reisenman et al11 reports 32 cases in the literature for endovascular repair of
aortobronchial fistulas with 55% of patients having had previous thoracic aortic surgery. No
intraoperative mortalities were reported and 30-day mortality rate was 1.5%. The recurrence rate
was 9% with a mean follow-up of 21.5 months. Only 3 cases required further interventions.
Reported average length of stay was 11.5 days.11
Conclusion
Finally, outcomes of TEVAR for ABF seem to be promising, with low short-term mortality and
morbidity as compared to open surgery for a traditionally high-risk condition. Other advantages
that minimally invasive surgery provides and should not be overlooked include shorter
hospitalization, less postoperative pain, and faster recovery. However, long-term follow-up
studies need to be conducted to further demonstrate the durability of this approach in treating
ABF.
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